Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response (2015)
- Autores:
- Autores USP: ANDRADE, JURANDYR MOREIRA DE - FMRP ; TIEZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- Assuntos: COLO UTERINO; QUIMIOTERAPIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Abstracts
- Nome do evento: International Meeting of the European Society of Gynaecological Oncology
-
ABNT
SOUZA, C. B. de et al. Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. 2015, Anais.. Nice: ESGO, 2015. . Acesso em: 23 abr. 2024. -
APA
Souza, C. B. de, Andrade, J. M. de, Schiavon, V. F., Clagnan, W. S., & Tiezzi, D. G. (2015). Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. In Abstracts. Nice: ESGO. -
NLM
Souza CB de, Andrade JM de, Schiavon VF, Clagnan WS, Tiezzi DG. Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. Abstracts. 2015 ;[citado 2024 abr. 23 ] -
Vancouver
Souza CB de, Andrade JM de, Schiavon VF, Clagnan WS, Tiezzi DG. Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response. Abstracts. 2015 ;[citado 2024 abr. 23 ] - Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
- Primary adenocarcinoma of the fallopian tube as an incidental finding during surgery in a postmenopausal patient with unspecific pelvic pain
- Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients
- Germ cells and mammary gland transcritome comparison generate a powerful gene expression profile that predicts breast cancer survival
- Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
